Skip to main content

Table 1 Clinical characteristics of patients

From: Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer

Clinical characteristics

Frozen samples (N = 108)

Paraffin samples (N = 132)

All (N = 240)

Age

48.12 ± 11.47

53.32 ± 8.79

50.98 ± 10.40

FIGO stage

   

I–II

23

–

23

III–IV

85

132

217

Grade (serous)

   

3

74

132

206

1

17

–

17

Grade (mucinous and endometrioid)

   

3

11

–

11

2

1

–

1

1

5

–

5

Histology types

   

Serous

91

132

223

Mucinous

14

–

14

Endometrioid

3

–

3

Surgical debulking

   

Optimal

76

96

172

Suboptimal

32

36

68

Chemotherapy outcome

   

Chemoresistant

55

56

111

Chemosensitive

53

76

129

Postoperative chemotherapy scheme

   

TP (paclitaxel plus cisplatin)

57

58

115

TC (paclitaxel plus carboplatin)

51

74

125